ReNeuron Group PLC (RQE.L)

Pharmaceuticals - Generic & Specialty

Register or Sign in to receive email alerts for items in your favourites whenever we write about them
 

Share Price

Share Intraday Performance
0.0p
+1.0p (+1.03%)
Bid: 97.0p Offer: 99.0p
As of: 08 Feb 2018 00:00
 
Market Capitalisation: £31.01 million
Shares In Issue: 31.65 million
PE: 0
Dividend Yield: 0

Share Performance

52 week high:   178.0p on 10-Jan-18
52 week low:   1.4p on 18-Jan-18

Financial History

to Mar '15to Mar '16to Mar '17
Turnover£0m£0m£0m
EPS-49.8p-43.5p-45.9p
Operating Profit-£10m-£14m-£20m
Total Operating Expense£10m£14m£20m
Net Profit-£9m-£11m-£16m
Net Profit Before Taxes-£10m-£13m-£18m
Net Profit After Taxes-£9m-£11m-£16m

Sponsored by:

Company Information
Number of Shares Out 31.65m
Number of Shares Floating 30.47m
Number of Common Share Holders
Number of Employees 53
Key Figures
Volume (10 day Avg.) 0.04462m
Turnover £0.05m
Profit Before Tax £-18.13m
EPS -49.21p
Cashflow Per Share -48.68p
Cash Per Share 167.67p